Evariant, a healthcare provider CRM platform, has raised $42.3 million in a Series C financing that values it at $169 million. Goldman Sachs led the round, which also saw participation from existing investors Health Enterprise Partners and Lightspeed Venture Partners. Evariant offers an end-to-end healthcare CRM platform that helps health systems attract profitable patient volume and connect patients with providers around their care. The company previously secured an $18.3 million Series B investment in May 2014 that generated a valuation of $98 million. As part of the most recent round, Jason Kreuziger of Goldman Sachs has joined the Board of Directors.